When was Biophore founded?

Biophore was founded in 2007 and raised its 1st funding round 2 years after it was founded.

Where is Biophore located?

Biophore is headquartered in Hyderabad, India. It is registered at Plot No: 92, 1-98/2/92, Kavuri Hills, Phase-II, Jubilee Hills, Hyderabad, Hyderabad, Telangana, India, 500033.

Who is the current CEO of Biophore?

Jagadeesh Babu Rangisetty of Biophore. They have also founded 1 company and are an angel investors in 1 startup.

How many employees does Biophore have?

As of Aug 31, 2025, Biophore has 664 employees, reflecting a 8% year-over-year growth in headcount.

Is Biophore a funded company?

Biophore is a funded company, having raised a total of $2.74M across 3 funding rounds to date. The company's 1st funding round was a $***** Angel round, raised on Dec 15, 2009.

How much is Biophore worth?

The latest valuation of Biophore is ₹***** as of Feb 05, 2014.

When was the latest funding round of Biophore?

Biophore's latest funding was a $***** Seed round on Feb 05, 2014, with participation from 1 investor. Its primary sector is Biopharma Outsourcing. In India, the Biopharma Outsourcing sector has seen $270M in funding in 2026 to date.

What is the annual revenue of Biophore?

Annual revenue of Biophore is ₹457Cr as on Mar 31, 2025.

Where does Biophore rank among its competitors?

Biophore ranks 7th amongst 369 active competitors, of which 16 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was Nucleus RadioPharma, which secured an undisclosed amount in Jun, 2024.

Who are the top competitors of Biophore?

Biophore's top competitors include Aizant, Almac Group and Concord Biotech. Among them, Nucleus RadioPharma secured the most recent funding round in June, 2024.

Biophore - 2026 Company Profile, Team, Funding, Competitors & Financials

Biophore is a seed company based in Hyderabad (India), founded in 2007 by Jagadeesh Babu Rangisetty and Manik Reddy Pullagurla. It operates as a Development and manufacturing of niche pharmaceutical products for the generic industry. Biophore has raised $2.74M in funding from Ontario, with a current valuation of ₹*****. The company has 369 active competitors, including 16 funded and 91 that have exited. Its top competitors include companies like Aizant, Almac Group and Concord Biotech.

Company Details

Biophore, is a pharma company with its own product portfolio of niche generic, branded and grandfather products and also in the development and manufacture of APIs for oncology medications, contrast and diagnostic media.They claim to have filed for 50+ patents and 70+ DMFs in the US, EU and also to other authorities in Canada, China and Turkey. They claim that their manufacturing facilities are FDA approved and customized units in their facilities for the manufacture of peptides, hormones, colored APIs, oncology and high potent drugs products.

Website: biophore.com
Social
Email ID: *****@biophore.com
Phone Number: +91 **********
Registered Address: Plot No: 92, 1-98/2/92, Kavuri Hills, Phase-II, Jubilee Hills, Hyderabad, Hyderabad, Telangana, India, 500033

Key Metrics

Founded Year

2007

Location

Hyderabad, India

Stage

Seed

Total Funding

$2.74M in 3 rounds

Latest Funding Round

Seed, Feb 05, 2014, $*****

Post Money Valuation

₹***** as on Feb 05, 2014

Investors

Ontario & 6 more

Ranked

7^th among 369 active competitors

Annual Revenue

₹457Cr as on Mar 31, 2025

Employee Count

664 as on Aug 31, 2025

Investment & Acquisitions

Azico Biophore & 1 more

Similar Companies

Aizant & 414 more

View Biophore's full profile

Biophore is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
VIVERE IMAGING PRIVATE LIMITED CIN: U24230TG2020PTC139316 , India, Active	Feb 18, 2020	$5.36M (As on Mar 31, 2025)	62 (As on Mar 01, 2026)
BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED CIN: U24232TG2007PTC053381 , India, Active	Mar 29, 2007	$54.1M (As on Mar 31, 2025)	693 (As on Mar 01, 2026)

Biophore has raised a total funding of $2.74M over 3 rounds. Its first funding round was on Dec 15, 2009. Its latest funding round was a Seed round on Feb 05, 2014 for $*****. 1 investor participated in its latest round. Biophore has 1 institutional investor and 6 angel investors.

Here is the list of recent funding rounds of Biophore:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Feb 05, 2014	8332243	Seed	4953065	9033608	4209163	4951612
Feb 14, 2012	2972633	Seed	2466873	9570191	7485532	8724765
Dec 15, 2009	3152487	Angel	3446774	6403014	Nimmagadda Ramprasad & 1 more	Jagadeesh Babu Rangisetty & 1 more

Access funding benchmarks and valuations. Sign up today!

View details of Biophore's funding rounds and investors

The founders of Biophore are Jagadeesh Babu Rangisetty and Manik Reddy Pullagurla. Jagadeesh Babu Rangisetty is the CEO of Biophore.

Here are the details of Biophore's key team members:

Jagadeesh Babu Rangisetty: Co-Founder & CEO of Biophore and founder of 1 other company. They are also an angel investor in 1 startup and serve on the board of 1 company.
Contact Info: 1 email address
Manik Reddy Pullagurla: Co-Founder & CSO of Biophore. They are also an angel investor in 1 startup and serve on the board of 1 company.
Contact Info: 1 email address

Biophore's Board of Directors

Biophore's board has 5 active members. Jagadeesh Babu Rangisetty, Manik Reddy Pullagurla and Ramprasad Nimmagadda are part of team and Madhusudan Rao Kothapalli and Rangisetty Jagadesh Babu are independent board members.

Here is the list of Biophore's board of directors:

Name	Type	Representing	Status	Duration
Jagadeesh Babu Rangisetty	Team	-	Current	19y 1m
Ramprasad Nimmagadda	Team	-	Current	14y 7m
pdzfwea	Team	-	Past	2y 3m
nplobcm	Team	-	Past	4y 3m
Rangisetty Jagadesh Babu	Independent board member	-	Current	8y 5m
liqxhaf	Independent board member	-	Past	8y 3m

View details of Biophore's Founder profiles and Board Members

Biophore's employee count trend

Biophore has 664 employees as of Aug 25. The total employee count is 7.0% more than what it was in Aug 24. Here is Biophore's employee count trend over the years:

Uncover Biophore's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Biophore include Aizant, Almac Group and Concord Biotech. Here is the list of Top 10 competitors of Biophore, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Aizant 2005, Hyderabad (India), Series A	Company offering contract development services for small molecules	$16.8M	Zephyr Management, Zephyr Peacock & 39 others	60/100
2nd	Almac Group 2001, Craigavon (United Kingdom), Series D	CRAMS company offering preclinical development and CDMO services, also offering companion diagnostic development	$339M	Genomic Health, Gates & 4 others	57/100
3rd	Concord Biotech 2000, Ahmedabad (India), Public	CDMO focused on manufacturing API	-	Quadria Capital, Helix Investments & 18 others	56/100
4th	Nucleus RadioPharma 2022, Rochester (United States), Series A	CDMO focused on providing of radiopharmaceuticals manufacturing and supply chain services	$72.1M	Eclipse, AstraZeneca & 7 others	55/100
5th	Indoco Remedies 1947, Mumbai (India), Public	Provider of APIs manufacturing and formulation services	-	Baring Private Equity Partners	54/100
6th	Amino 1958, Frellstedt (Germany), Unfunded	CDMO focused on amino acids and small molecules	-	-	53/100
7th	Biophore 2007, Hyderabad (India), Seed	Development and manufacturing of niche pharmaceutical products for the generic industry	$2.74M	Ontario & 6 others	52/100
8th	Sabinsa 1988, East Windsor (United States), Unfunded	Manufacturing and marketing nutraceuticals, cosmeceuticals and fine chemicals	-	-	52/100
9th	Galenicum 2003, Barcelona (Spain), Late Stage	Turnkey solutions for drug development, manufacturing and regulatory approvals	-	Peninsula Capital	52/100
10th	Wanbury Limited 1990, Mumbai (India), Public	Manufacturer of anti-diabetic drugs	-	-	51/100